Delivery is always problematic due to poor aqueous solubility, poor permeation, low systemic availability, instability and extensive first pass metabolism. We developed a delivery system technology to improve metabolite bio availability. We reduced bioactive substances to nanoscale to improve uptake, absorption, and bioavailability in the body compared to substances in bulk.